Stereotactic body radiotherapy for hepatocellular carcinoma: Five-year prospective registry outcomes from an Australian tertiary transplant centre

Figure 1 Treatment outcomes. A: Local control rates, with death and distant progression as competing events; B: Progression-free survival, with failure defined as death, distant relapse, extrahepatic failure, or local failure; C: Cumulative incidence of local failure, with death, distant intrahepatic relapse, and extrahepatic failure as competing events.

Figure 2 Kaplan-Meier survival outcomes. A: Overall survival; B: Overall survival stratified by Barcelona Clinic Liver Cancer stage. BCLC: Barcelona Clinic Liver Cancer stage.

Figure 3 Kaplan-Meier overall survival curves stratified by Child-Pugh score. A: Baseline Child-Pugh score: Child-Pugh 5-6 (Child-Pugh A) vs Child-Pugh 7-8 (Child-Pugh B); B: Child-Pugh change at 3 months (< 2 vs ≥ 2 points increase); C: Child-Pugh change at 6 months (< 2 vs ≥ 2 points increase); D: Child-Pugh change at 12 months (< 2 vs ≥ 2 points increase).